Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: A drug development perspective

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 4, 2013, Pages 723-731

  Dukeck, R ^a   Sieger, P ^a   Karmwar, P ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Amorphous; Dissolution; Drug polymer interaction; Solid dispersions; Stability; Telmisartan

Indexed keywords

TELMISARTAN;

AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG CONFORMATION; DRUG SOLUBILITY; DRUG STABILITY; MAXIMUM PLASMA CONCENTRATION; MELTING POINT; PARTICLE SIZE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

EID: 84879809930     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.05.003     Document Type: Article

References (50)

1. Alonzo, D.E., Gao, Y., Zhou, D., Mo, H., Zhang, G.G.Z., Taylor, L.S., 2011. Dissolution and precipitation behavior of amorphous solid dispersions. J. Pharm. Sci. 100, 3316-3331.
2. Aoki, A., Ogawa, T., Sumino, H., Kumakura, H., Takayama, Y., Ichikawa, S., Nitta, K., 2010. Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients. Heart Vessels 25, 195-202.
3. Bøtker, J.P., Karmwar, P., Strachan, C.J., Cornett, C., Tian, F., Zujovic, Z., Rantanen, J., Rades, T., 2011. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions. Int. J. Pharm. 417, 112-119.
4. Castellanos, A., 2005. The relationship between attractive interparticle forces and bulk behaviour in dry and uncharged fine powders. Adv. Phys. 54, 263-376.
5. Cesteros, L.C., Meaurio, E., Katime, I., 1993. Miscibility and specific interactions in blends of poly(hydroxy methacrylates) with poly(vinylpyridines). Macromolecules 26, 2323-2330.
6. Chee, K.K., 1995. Thermodynamic study of glass transitions in miscible polymer blends. Polymer 36, 809-813.
7. Chieng, N., Aaltonen, J., Saville, D., Rades, T., 2009. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. Eur. J. Pharm. Biopharm. 71, 47-54.
8. Craig, D.Q.M., Royall, P.G., Kett, V.L., Hopton, M.L., 1999. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int. J. Pharm. 179, 179-207. (Pubitemid 29131430)
9. Dinnebier, R.E., Sieger, P., Nar, H., Shankland, K., David, W.I.F., 2000. Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction. J. Pharm. Sci. 89, 1465-1479.
10. Flory, P.J., 1953. Principles of Polymer Chemistry. Cornell University Press, Ithaca.
11. Graeser, K.A., Patterson, J.E., Rades, T., 2009. Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin. Curr. Drug Deliv. 6, 374-382.
12. Gupta, P., Kakumanu, V.K., Bansal, A.K., 2004. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 21, 1762-1769. (Pubitemid 39390086)
13. Haleblian, J.K., 1975. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 64, 1269-1288.
14. He, Y., Zhu, B., Inoue, Y., 2004. Hydrogen bonds in polymer blends. Prog. Polym. Sci. 29, 1021-1051.
15. Heinz, A., Savolainen, M., Rades, T., Strachan, C.J., 2007. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and nearinfrared spectroscopy. Eur. J. Pharm. Sci. 32, 182-192. (Pubitemid 47532710)
16. Imaizumi, H., Nambu, N., Nagai, T., 1980. Pharmaceutical interaction in dosage forms and processing (18). Stability and several physical-properties of amorphous and crystalline forms of indomethacin. Chem. Pharm. Bull. 28, 2565-2569. (Pubitemid 11208718)
17. Ivanisevic, I., 2010. Physical stability studies of miscible amorphous solid dispersions. J. Pharm. Sci. 99, 4005-4012.
18. Jung, J.-Y., Yoo, S.D., Lee, S.-H., Kim, K.-H., Yoon, D.-S., Lee, K.-H., 1999. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int. J. Pharm. 187, 209-218. (Pubitemid 29443901)
19. Kang, P.M., Landau, A.J., Eberhardt, R.T., Frishman, W.H., 1994. Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system. Am. Heart J. 127, 1388-1401. (Pubitemid 24176033)
20. Karmwar, P., Boetker, J.P., Graeser, K.A., Strachan, C.J., Rantanen, J., Rades, T., 2011a. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin. Eur. J. Pharm. Sci. 44, 341-350.
21. Karmwar, P., Graeser, K., Gordon, K.C., Strachan, C.J., Rades, T., 2011b. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods. Int. J. Pharm. 417, 94-100.
22. Karmwar, P., Graeser, K., Gordon, K.C., Strachan, C.J., Rades, T., 2012. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin. Eur. J. Pharm. Biopharm. 80, 459-464.
23. Li, B., Wen, M., Li, W., He, M., Yang, X., Li, S., 2011. Preparation and characterization of baicalin-poly-vinylpyrrolidone coprecipitate. Int. J. Pharm. 408, 91-96.
24. Löbenberg, R., Amidon, G.L., 2000. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50, 3-12. (Pubitemid 30326685)
25. Marsac, P., Shamblin, S., Taylor, L., 2006. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm. Res. 23, 2417-2426. (Pubitemid 44511522)
26. Marsac, P., Li, T., Taylor, L., 2009. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm. Res. 26, 139-151.
27. Matteucci, M.E., Brettmann, B.K., Rogers, T.L., Elder, E.J., Williams, R.O., Johnston, K.P., 2007. Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol. Pharm. 4, 782-793. (Pubitemid 350004278)
28. Meaurio, E., Zuza, E., Sarasua, J.-R., 2005. Miscibility and specific interactions in blends of poly(l-lactide) with poly(vinylphenol). Macromolecules 38, 1207-1215. (Pubitemid 40308179)
29. Mullin, J.W., 1961. Crystallization. International Scientific Series, Butterworths, London.
30. Narang, A.S., Srivastava, A.K., 2002. Evaluation of solid dispersions of clofazimine. Drug Dev. Ind. Pharm. 28, 1001-1013.
31. Nishi, T., Wang, T.T., 1975. Melting point depression and kinetic effects of cooling on crystallization in poly(vinylidene fluoride)-poly(methyl methacrylate) mixtures. Macromolecules 8, 909-915.
32. Ogihara, T., Higashimori, K., Masuo, K., Mikami, H., 1993. Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension. Clin. Ther. 15, 684-691. (Pubitemid 23274450)
33. Park, Y., Veytsman, B., Coleman, M., Painter, P., 2005. The miscibility of hydrogenbonded polymer blends: two self-associating polymers. Macromolecules 38, 3703-3707. (Pubitemid 40672499)
34. Patterson, J.E., James, M.B., Forster, A.H., Lancaster, R.W., Butler, J.M., Rades, T., 2007. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int. J. Pharm. 336, 22-34. (Pubitemid 46551551)
35. Patterson, J.E., James, M.B., Forster, A.H., Rades, T., 2008. Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers. Drug Develop. Ind. Pharm. 34, 95-106. (Pubitemid 351156956)
36. Sarode, A.L., Sandhu, H., Shah, N., Malick, W., Zia, H., 2013. Hot melt extrusion (HME) for amorphous solid dispersions: Predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur. J. Pharm. Sci. 48, 371-384.
37. Savolainen, M., Heinz, A., Strachan, C., Yliruusi, J., Rades, T., Sandler, N., 2007. Screening for differences in the amorphous state of indomethacin using multivariate visualization. Eur. J. Pharm. Sci. 32, S8.
38. Savolainen, M., Kogermann, K., Heinz, A., Aaltonen, J., Peltonen, L., Strachan, C., Yliruusi, J., 2009. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Eur. J. Pharm. Biopharm. 71, 71-79.
39. Seefeldt, K., Miller, J., Alvarez-Núñez, F., Rodríguez-Hornedo, N., 2007. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. J. Pharm. Sci. 96, 1147-1158. (Pubitemid 46797483)
40. Sethia, S., Squillante, E., 2004. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272, 1-10. (Pubitemid 38293005)
41. Shamblin, S.L., Taylor, L.S., Zografi, G., 1998. Mixing behavior of colyophilized binary systems. J. Pharm. Sci. 87, 694-701. (Pubitemid 28268567)
42. Six, K., Verreck, G., Peeters, J., Brewster, M., Mooter, G.V.D., 2004. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93, 124-131. (Pubitemid 38081820)
43. Strachan, C.J., Rades, T., Gordon, K.C., 2007. A theoretical and spectroscopic study of gamma-crystalline and amorphous indometacin. J. Pharm. Pharmacol. 59, 261-269. (Pubitemid 46203064)
44. Taylor, L.S., Zografi, G., 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14, 1691-1698. (Pubitemid 28062912)
45. Tian, Y., Jones, D.S., Li, S., Andrews, G.P., 2012. Construction of drug-polymer thermodynamic phase diagrams using flory-huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions. Mol. Pharm.
46. Usui, F., Maeda, K., Kusai, A., Nishimura, K., Keiji, Y., 1997. Inhibitory effects of water-soluble polymers on precipitation of RS-8359. Int. J. Pharm. 154, 59-66. (Pubitemid 27326820)
47. Van den Mooter, G., Wuyts, M., Blaton, N., Busson, R., Grobet, P., Augustijns, P., Kinget, R., 2001. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12, 261-269.
48. Vanhee, S., Koningsveld, R., Berghmans, H., Šolc, K., Stockmayer, W.H., 2000. Thermodynamic stability of immiscible polymer blends. Macromolecules 33, 3924-3931.
49. Wiranidchapong, C., Tucker, I.G., Rades, T., Kulvanich, P., 2008. Miscibility and interactions between 17β-estradiol and Eudragit® RS in solid dispersion. J. Pharm. Sci. 97, 4879-4888.
50. Yoshioka, M., Hancock, B.C., Zografi, G., 1995. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J. Pharm. Sci. 84, 983-986.